(Q34446583)

English

The effect of fluoxetine in patients with pain and constipation-predominant irritable bowel syndrome: a double-blind randomized-controlled study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

The effect of fluoxetine in patients with pain and constipation-predominant irritable bowel syndrome: a double-blind randomized-controlled study (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

0 references

irritable bowel syndrome

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Reza Malekzadeh

5

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

author name string

Vahedi H

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Merat S

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Rashidioon A

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Ghoddoosi A

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

language of work or name

0 references

publication date

1 September 2005

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

381-385

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Review article: tegaserod

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02566.X

21 January 2018

Tegaserod is effective in the initial and retreatment of irritable bowel syndrome with constipation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02566.X

21 January 2018

Management of the irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02566.X

21 January 2018

Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02566.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02566.X

21 January 2018

Patients with constipation-predominant irritable bowel syndrome (IBS) may have elevated serotonin concentrations in colonic mucosa as compared with diarrhea-predominant patients and subjects with normal bowel habits

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02566.X

21 January 2018

The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02566.X

21 January 2018

Paroxetine to treat irritable bowel syndrome not responding to high-fiber diet: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02566.X

21 January 2018

Coeliac disease presenting with symptoms of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02566.X

21 January 2018

Identifiers

10.1111/J.1365-2036.2005.02566.X

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34446583&oldid=1975863239"